glp 1 review GLP-1 receptor agonists show promise in treating substance use disorders IUPHAR review – Glucagon-like peptide-1
Description
openPR disclaims liability for any content contained in this release
Cell 185(14):2478-2494.e28 [DOI] [PMC free article] [PubMed] [Google Scholar] Zheng Z, Zong Y, Ma Y, Tian Y (2024) Glucagon-like peptide-1 receptor: mechanisms and advances in therapy
Das Akronym GIP wird seither als Glukose-abhngiges Insulinotropes Polypeptid interpretiert
Are there contraindications I should know about
1.7% with placebo
